Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs
Author(s) -
О. Д. Остроумова,
A A Zykova,
М. Л. Максимов
Publication year - 2016
Publication title -
systemic hypertension
Language(s) - English
Resource type - Journals
eISSN - 2542-2189
pISSN - 2075-082X
DOI - 10.26442/sg29149
Subject(s) - metabolic syndrome , medicine , disease , kidney disease , obesity , intensive care medicine , bioinformatics , pharmacology , biology
In the article shows the questions of prevalence, diagnosis and prognostic significance of renal damage in metabolic syndrome. Discusses the pathogenetic mechanisms of development and progression of chronic kidney disease in individuals with obesity. Approaches to selection of antihypertensive drugs, advantages and limitations of the major classes of antihypertensive drugs in the treatment of metabolic syndrome, arterial hypertension combined with renal disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom